Pediatric empiric antibiotic use and resistance patterns at a single tertiary care hospital in Tanzania

Anneka M Hooft1,2, Kum Su Sunny Hwang3, Raya Mussa4

  • 1Departments of Emergency Medicine and Paediatrics, University of California, San Francisco, San Francisco, CA, USA. Anneka.hooft@ucsf.edu.

BMC Pediatrics
|July 9, 2026
PubMed

Insights

Pediatric antibiotic use in Tanzania shows ceftriaxone is common, but resistance is high in gram-negative bacteria like E. coli. This highlights the need for updated antimicrobial stewardship programs to combat rising drug resistance.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Stewardship
  • Clinical Microbiology

Background:

  • Pediatric-specific antibiograms are scarce in Tanzanian public hospitals.
  • Empiric antibiotic use patterns in pediatric emergency care are under-documented.
  • Understanding resistance and prescribing is crucial for pediatric antimicrobial stewardship (AMS).

Purpose of the Study:

  • To assess pediatric empiric antibiotic use in the emergency department.
  • To analyze microbiology results and resistance patterns in children.
  • To establish a baseline for pediatric antimicrobial stewardship at Muhimbili National Hospital (MNH), Tanzania.

Main Methods:

  • Retrospective review of electronic medical records for children in the EMD.
  • Documentation of empiric antibiotic prescriptions and their indications.
  • Analysis of blood and urine cultures to determine resistance patterns and construct a pediatric antibiogram.

Main Results:

  • Ceftriaxone was the most frequent antibiotic prescribed (72%), particularly for lower respiratory infections.
  • Low susceptibility to ceftriaxone was observed in gram-negative isolates (e.g., 20% in K. pneumoniae, 18% in E. coli).
  • Over 90% of Enterobacterales exhibited multidrug resistance (MDR).

Conclusions:

  • Ceftriaxone is widely used, aligning with local sepsis guidelines but not national infectious disease guidelines.
  • High rates of ceftriaxone resistance in gram-negative organisms necessitate urgent review of prescribing practices.
  • Future quality improvement initiatives must integrate antibiotic prescribing data and local epidemiology to refine treatment guidelines.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Antibiotic Selection00:57

Antibiotic Selection

Overview